NEW YORK (GenomeWeb News) – Genetic-association software maker Golden Helix has expanded its collaboration program for copy number variation analysis research to include five new academic partners, the company said today.
Golden Helix said it has agreed to provide data processing, quality control analysis, and consulting services in exchange for the purchase of its software and feedback on its products and services.
The new collaborators working with the company include Imperial College London, the University of Edinburgh, the University of Alabama at Birmingham, the University Hospital of Schleswig-Holstein in Kiel, Germany, and the Hospital for Sick Children in Toronto.
The company launched the collaboration program in January. Initial partners included researchers from the University of California Los Angeles, the Zucker Hillside Hospital, Montreal Heart Institute, Emory University, Case Western Reserve University, and the University at Lubeck, Germany.
"Copy number analysis is an exciting area of research because of its potential impact on how we understand and treat disease," Golden Helix CEO Christophe Lambert said in a statement. “Collaborating with these leading institutions will be invaluable for helping develop and improve the analytic methods needed to advance this field.”
These collaborations will cover a number of diseases and sample characteristics and data generated from Illumina and Affymetrix genotyping platforms, said Golden Helix.